Izzeddin Alsalahat

719 citations
22 papers · 555 indexed · h-index 14

Izzeddin Alsalahat

22 papers receiving 545 citations

Peers

Izzeddin Alsalahat
Comparison fields: 5 of 84
  • Pharmaceutical Science 204
  • Drug Discovery 2
  • Molecular Medicine 29
  • Biological Psychiatry 13
  • Pharmacology 70
Replace Kowthavarapu Venkata Krishna with:
Kowthavarapu Venkata Krishna India
Kilambi Pundarikakshudu India
Mojdeh Mohammadi Iran
Karthik Arumugam India
Péter Sipos Hungary
Mei‐Na Jin China
Badruddeen Badruddeen India
Guru R. Valicherla India
Xiaohong Liu China
Izzeddin Alsalahat relative to Kowthavarapu Venkata Krishna India Kowthavarapu Venkata Krishna's profile →
Citations per field
00.5×2.6×
Kowthavarapu Venkata Krishna · 1×
Citations per year

Countries citing papers authored by Izzeddin Alsalahat

Since Specialization
Citations

This map shows the geographic impact of Izzeddin Alsalahat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izzeddin Alsalahat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izzeddin Alsalahat more than expected).

Fields of papers citing papers by Izzeddin Alsalahat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izzeddin Alsalahat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izzeddin Alsalahat. The network helps show where Izzeddin Alsalahat may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Izzeddin Alsalahat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Izzeddin Alsalahat Line = papers co-authored together Izzeddin Alsalahat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202417
2 202315
3 20239
4 202220
5 202215
6 20224
7 202223
8 202212
9 20223
10 202266
11 202237
12 202264
13 202153
14 20219
15 20215
16 202082
17 202045
18 201817
19 20184
20 20154

About Izzeddin Alsalahat

Izzeddin Alsalahat is a scholar working on Pharmaceutical Science, Analytical Chemistry and Toxicology, having authored 22 papers that have together received 555 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (5 papers), Analytical Chemistry and Chromatography (4 papers), Berberine and alkaloids research (3 papers), Drug Solubulity and Delivery Systems (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Synthesis and Biological Evaluation (2 papers). The work is most often cited by research in Pharmaceutical Science (204 citations), Drug Discovery (2 citations) and Molecular Medicine (29 citations). Izzeddin Alsalahat has collaborated with scholars based in United Kingdom, Saudi Arabia and Egypt. Frequent co-authors include Ibrahim A. Naguib, Hussein M. Eid, Mohammed H. Elkomy, Mohammed M. Ghoneim, Asma Ismail Mahmod, Wamidh H. Talib, Safa Daoud, Sally Freeman, Reem I. Alsantali and Marwa F. Ahmed. Their work appears in journals such as British Journal of Pharmacology, Molecules and Sensors.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026